JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C200163200 on May 28, 2002

J. Biol. Chem., Vol. 277, Issue 28, 24851-24854, July 12, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/28/24851    most recent
C200163200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oganesyan, V.
Right arrow Articles by Esmon, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oganesyan, V.
Right arrow Articles by Esmon, C. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ACCELERATED PUBLICATION
The Crystal Structure of the Endothelial Protein C Receptor and a Bound Phospholipid*

Vaheh OganesyanDagger , Natalia Oganesyan§, Simon Terzyan, Dongfeng QuDagger , Zbigniew Dauter||, Naomi L. Esmon**, and Charles T. EsmonDagger §**Dagger Dagger §§

From the Dagger  Cardiovascular Biology Research Program, § Howard Hughes Medical Institute, and  Department of Crystallography, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma 73104, || SAIC/NCI-Frederick, National Institutes of Health, Frederick, Maryland 21702, and the Departments of ** Pathology and Dagger Dagger  Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104

The endothelial cell protein C receptor (EPCR) shares ~20% sequence identity with the major histocompatibility complex class 1/CD1 family of molecules, accelerates the thrombin-thrombomodulin-dependent generation of activated protein C, a natural anticoagulant, binds to activated neutrophils, and can undergo translocation from the plasma membrane to the nucleus. Blocking protein C/activated protein C binding to the receptor inhibits not only protein C activation but the ability of the host to respond appropriately to bacterial challenge, exacerbating both the coagulant and inflammatory responses. To understand how EPCR accomplishes these multiple tasks, we solved the crystal structure of EPCR alone and in complex with the phospholipid binding domain of protein C. The structures were strikingly similar to CD1d. A tightly bound phospholipid resides in the groove typically involved in antigen presentation. The protein C binding site is outside this conserved groove and is distal from the membrane-spanning domain. Extraction of the lipid resulted in loss of protein C binding, which could be restored by lipid reconstitution. CD1d augments the immune response by presenting glycolipid antigens. The EPCR structure is a model for how CD1d binds lipids and further suggests additional potential functions for EPCR in immune regulation, possibly including the anti-phospholipid syndrome.


* This research was supported by Specialized Centers of Research Grant P50 HL54502 awarded by the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and the structure factors (code 1L8J and 1LQV) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

§§ An Investigator for the Howard Hughes Medical Institute. To whom correspondence should be addressed: Howard Hughes Medical Inst., Oklahoma Medical Research Foundation, 825 N. E. 13th St., Oklahoma City, OK 73104. Tel.: 405-271-7571; Fax: 405-271-3137; E-mail: Charles-Esmon@omrf.ouhsc.edu.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Biophys. JHome page
J. Diao and E. Tajkhorshid
Indirect Role of Ca2+ in the Assembly of Extracellular Matrix Proteins
Biophys. J., July 1, 2008; 95(1): 120 - 127.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M. Xue, L. March, P. N Sambrook, K. Fukudome, and C. J Jackson
Endothelial protein C receptor is overexpressed in rheumatoid arthritic (RA) synovium and mediates the anti-inflammatory effects of activated protein C in RA monocytes
Ann Rheum Dis, December 1, 2007; 66(12): 1574 - 1580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, J.-S. Bae, C. Manithody, and A. R. Rezaie
Identification of a Specific Exosite on Activated Protein C for Interaction with Protease-activated Receptor 1
J. Biol. Chem., August 31, 2007; 282(35): 25493 - 25500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ndonwi, G. J. Broze Jr., S. Agah, A. E. Schmidt, and S. P. Bajaj
Substitution of the Gla Domain in Factor X with That of Protein C Impairs Its Interaction with Factor VIIa/Tissue Factor: LACK OF COMPARABLE EFFECT BY SIMILAR SUBSTITUTION IN FACTOR IX
J. Biol. Chem., May 25, 2007; 282(21): 15632 - 15644.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin
The cytoprotective protein C pathway
Blood, April 15, 2007; 109(8): 3161 - 3172.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie
Engineering a Disulfide Bond to Stabilize the Calcium-binding Loop of Activated Protein C Eliminates Its Anticoagulant but Not Its Protective Signaling Properties
J. Biol. Chem., March 23, 2007; 282(12): 9251 - 9259.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-S. Bae, L. Yang, and A. R. Rezaie
Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells
PNAS, February 20, 2007; 104(8): 2867 - 2872.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. J. S. Preston, E. Ajzner, C. Razzari, S. Karageorgi, S. Dua, B. Dahlback, and D. A. Lane
Multifunctional Specificity of the Protein C/Activated Protein C Gla Domain
J. Biol. Chem., September 29, 2006; 281(39): 28850 - 28857.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. B. Balazs, A. J. Fabian, C. T. Esmon, and R. C. Mulligan
Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow
Blood, March 15, 2006; 107(6): 2317 - 2321.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Li, X. Zheng, J.-M. Gu, G. L. Ferrell, M. Brady, N. L. Esmon, and C. T. Esmon
Extraembryonic expression of EPCR is essential for embryonic viability
Blood, October 15, 2005; 106(8): 2716 - 2722.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Saaren-Seppala, M. Jauhiainen, T. M. T. Tervo, B. Redl, P. K. J. Kinnunen, and J. M. Holopainen
Interaction of Purified Tear Lipocalin with Lipid Membranes
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3649 - 3656.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Dahlback and B. O. Villoutreix
Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway: Novel Insights Into Structure-Function Relationships and Molecular Recognition
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1311 - 1320.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Finigan, S. M. Dudek, P. A. Singleton, E. T. Chiang, J. R. Jacobson, S. M. Camp, S. Q. Ye, and J. G. N. Garcia
Activated Protein C Mediates Novel Lung Endothelial Barrier Enhancement: ROLE OF SPHINGOSINE 1-PHOSPHATE RECEPTOR TRANSACTIVATION
J. Biol. Chem., April 29, 2005; 280(17): 17286 - 17293.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Klein and N. Nikolaidis
The descent of the antibody-based immune system by gradual evolution
PNAS, January 4, 2005; 102(1): 169 - 174.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Hurtado, R. Montes, J.-C. Gris, M. L. Bertolaccini, A. Alonso, M. A. Martinez-Gonzalez, M. A. Khamashta, K. Fukudome, D. A. Lane, and J. Hermida
Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death
Blood, September 1, 2004; 104(5): 1369 - 1374.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. V. de Wouwer, D. Collen, and E. M. Conway
Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation
Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1374 - 1383.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Saposnik, J.-L. Reny, P. Gaussem, J. Emmerich, M. Aiach, and S. Gandrille
A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis
Blood, February 15, 2004; 103(4): 1311 - 1318.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. R. Rezaie and L. Yang
Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin
PNAS, October 14, 2003; 100(21): 12051 - 12056.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
D. Marsh
Lipid-binding proteins: Structure of the phospholipid ligands
Protein Sci., September 1, 2003; 12(9): 2109 - 2117.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. T. Esmon
The Protein C Pathway
Chest, September 1, 2003; 124(3_suppl): 26S - 32S.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
C. T. Esmon
Coagulation and inflammation
Innate Immunity, June 1, 2003; 9(3): 192 - 198.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
J.-M. Gu, J. T. B. Crawley, G. Ferrell, F. Zhang, W. Li, N. L. Esmon, and C. T. Esmon
Disruption of the Endothelial Cell Protein C Receptor Gene in Mice Causes Placental Thrombosis and Early Embryonic Lethality
J. Biol. Chem., November 1, 2002; 277(45): 43335 - 43343.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. T. Esmon
New Mechanisms for Vascular Control of Inflammation Mediated by Natural Anticoagulant Proteins
J. Exp. Med., September 2, 2002; 196(5): 561 - 564.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.